uniQure N.V. (QURE)
USD 8.91
(-8.62%)
USD 8.91
(-8.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -102.95 Million USD | -20.95% |
| 2022 | -85.12 Million USD | 79.76% |
| 2021 | -420.53 Million USD | -142.54% |
| 2020 | -173.38 Million USD | 43.1% |
| 2019 | -304.73 Million USD | -52.8% |
| 2018 | -199.42 Million USD | -43.27% |
| 2017 | -139.19 Million USD | -23.99% |
| 2016 | -112.26 Million USD | 44.24% |
| 2015 | -201.33 Million USD | -360.12% |
| 2014 | -43.75 Million USD | -101.58% |
| 2013 | -21.7 Million USD | -8877.44% |
| 2012 | 247.3 Thousand USD | 120.74% |
| 2011 | -1.19 Million USD | 94.92% |
| 2010 | -23.45 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 299.43 Million USD | 390.85% |
| 2024 Q2 | 246.56 Million USD | -17.66% |
| 2024 Q3 | -184.03 Million USD | -174.64% |
| 2023 Q3 | -91.18 Million USD | 75.65% |
| 2023 Q4 | -102.95 Million USD | -12.9% |
| 2023 Q2 | -374.51 Million USD | -3059.38% |
| 2023 FY | -102.95 Million USD | -20.95% |
| 2023 Q1 | -11.85 Million USD | 86.07% |
| 2022 Q2 | -361.4 Million USD | 7.21% |
| 2022 Q1 | -389.47 Million USD | 7.38% |
| 2022 FY | -85.12 Million USD | 79.76% |
| 2022 Q4 | -85.12 Million USD | 71.78% |
| 2022 Q3 | -301.59 Million USD | 16.55% |
| 2021 Q1 | -155.4 Million USD | 10.37% |
| 2021 FY | -420.53 Million USD | -142.54% |
| 2021 Q4 | -420.53 Million USD | 10.8% |
| 2021 Q3 | -471.44 Million USD | 17.33% |
| 2021 Q2 | -570.26 Million USD | -266.96% |
| 2020 Q1 | -269.4 Million USD | 11.59% |
| 2020 Q4 | -173.38 Million USD | 16.69% |
| 2020 FY | -173.38 Million USD | 43.1% |
| 2020 Q2 | -243.11 Million USD | 9.76% |
| 2020 Q3 | -208.11 Million USD | 14.4% |
| 2019 Q2 | -112.18 Million USD | 23.16% |
| 2019 Q3 | -331.55 Million USD | -195.54% |
| 2019 Q1 | -146 Million USD | 26.79% |
| 2019 Q4 | -304.73 Million USD | 8.09% |
| 2019 FY | -304.73 Million USD | -52.8% |
| 2018 FY | -199.42 Million USD | -43.27% |
| 2018 Q3 | -218.83 Million USD | 8.17% |
| 2018 Q2 | -238.31 Million USD | -98.58% |
| 2018 Q4 | -199.42 Million USD | 8.87% |
| 2018 Q1 | -120 Million USD | 13.4% |
| 2017 Q1 | -99.9 Million USD | 11.0% |
| 2017 FY | -139.19 Million USD | -23.99% |
| 2017 Q4 | -138.58 Million USD | -102.75% |
| 2017 Q3 | -68.34 Million USD | 18.26% |
| 2017 Q2 | -83.61 Million USD | 16.31% |
| 2016 Q4 | -112.26 Million USD | 17.61% |
| 2016 FY | -112.26 Million USD | 44.24% |
| 2016 Q3 | -136.24 Million USD | 16.47% |
| 2016 Q1 | -188.24 Million USD | 6.5% |
| 2016 Q2 | -163.12 Million USD | 13.35% |
| 2015 Q3 | -220.13 Million USD | -20.68% |
| 2015 Q2 | -182.4 Million USD | -613.08% |
| 2015 FY | -201.33 Million USD | -360.12% |
| 2015 Q4 | -201.33 Million USD | 8.54% |
| 2015 Q1 | -25.57 Million USD | 41.54% |
| 2014 Q1 | -96.39 Million USD | -326.53% |
| 2014 Q3 | -58.84 Million USD | 24.55% |
| 2014 Q2 | -77.99 Million USD | 19.09% |
| 2014 Q4 | -43.75 Million USD | 25.64% |
| 2014 FY | -43.75 Million USD | -101.58% |
| 2013 Q2 | 19.08 Million USD | 5564.54% |
| 2013 Q4 | -22.59 Million USD | 28.8% |
| 2013 Q1 | 336.98 Thousand USD | 36.26% |
| 2013 FY | -21.7 Million USD | -8877.44% |
| 2013 Q3 | -31.73 Million USD | -266.27% |
| 2012 FY | 247.3 Thousand USD | 120.74% |
| 2012 Q4 | 247.3 Thousand USD | 0.0% |
| 2011 FY | -1.19 Million USD | 94.92% |
| 2010 FY | -23.45 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -84.038% |
| Alkermes plc | -166.73 Million USD | 38.256% |
| Agenus Inc. | 274.13 Million USD | 137.555% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 105.506% |
| Aptorum Group Limited | 1.35 Million USD | 7686.405% |
| Ardelyx, Inc. | 34.51 Million USD | 398.305% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2505.397% |
| Bicycle Therapeutics plc | -481.46 Million USD | 78.617% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 384.686% |
| ChromaDex Corporation | -24.04 Million USD | -328.106% |
| Chimerix, Inc. | -25.51 Million USD | -303.46% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1577.467% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -334.814% |
| CRISPR Therapeutics AG | -150.84 Million USD | 31.75% |
| Precision BioSciences, Inc. | -85.41 Million USD | -20.537% |
| Dyadic International, Inc. | -6.37 Million USD | -1514.133% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -546.15% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1443.131% |
| Lantern Pharma Inc. | -21.7 Million USD | -374.357% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 6.863% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1105.067% |
| Incyte Corporation | -3.17 Billion USD | 96.758% |
| IO Biotech, Inc. | -140.69 Million USD | 26.829% |
| Jaguar Health, Inc. | 29.39 Million USD | 450.281% |
| Novavax, Inc. | -298.29 Million USD | 65.487% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2029.005% |
| Opthea Limited | 28.15 Million USD | 465.626% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -513.205% |
| ContextLogic Inc. | -232 Million USD | 55.625% |
| MiMedx Group, Inc. | -33.9 Million USD | -203.681% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1109.819% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -4343.237% |
| NextCure, Inc. | -6.47 Million USD | -1489.486% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -103.859% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1513.905% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 946.409% |
| Vaxcyte, Inc. | -368.22 Million USD | 72.041% |
| PDS Biotechnology Corporation | -32.7 Million USD | -214.749% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 695.85% |
| Pharming Group N.V. | 109.8 Million USD | 193.759% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -491.808% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 41.248% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -455.895% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -455.895% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1350.014% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1656.843% |
| Acelyrin, Inc. | -216.9 Million USD | 52.536% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1735.046% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -5871.636% |
| Summit Therapeutics Inc. | 34.67 Million USD | 396.911% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1413.318% |
| Senti Biosciences, Inc. | 1.74 Million USD | 6016.724% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 44.232% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -32.924% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1598.301% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 103289.367% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 16493.471% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 12.042% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 38.805% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 192.857% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1255.332% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 20.263% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1593.213% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 57.522% |
| Immix Biopharma, Inc. | -17.5 Million USD | -487.962% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 67.493% |
| MEI Pharma, Inc. | -3.7 Million USD | -2678.704% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 922.884% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 163.651% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 470.421% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1443.131% |
| Precigen, Inc. | -481 Thousand USD | -21303.534% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 831.134% |
| AlloVir, Inc. | -62.69 Million USD | -64.217% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -85.117% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 266.949% |
| ImmuCell Corporation | 10.99 Million USD | 1036.722% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 33.212% |
| Onconetix, Inc. | 5.33 Million USD | 2031.018% |
| PureTech Health plc | -167.19 Million USD | 38.425% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -237.988% |
| Elevation Oncology, Inc. | -19.11 Million USD | -438.503% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1997.189% |
| Seer, Inc. | -4.24 Million USD | -2328.09% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -328.302% |
| Innoviva, Inc. | 255.56 Million USD | 140.284% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -84.289% |
| ESSA Pharma Inc. | -33.62 Million USD | -206.205% |
| GlycoMimetics, Inc. | -40.98 Million USD | -151.195% |
| GT Biopharma, Inc. | -1.02 Million USD | -9983.35% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -51.883% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 268.064% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 23.216% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -643.007% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -256.577% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -136559.41% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -233.585% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1156.288% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3190.202% |
| Soligenix, Inc. | -4.95 Million USD | -1979.147% |
| Century Therapeutics, Inc. | 847 Thousand USD | 12254.782% |
| Kura Oncology, Inc. | -20.11 Million USD | -411.736% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -151.554% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1125.899% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 5751.385% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3120.238% |
| Autolus Therapeutics plc | -186.59 Million USD | 44.828% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -108.809% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 62.671% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 400.429% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 162.634% |
| GRI Bio, Inc. | -1.79 Million USD | -5638.629% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1046.059% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -209.562% |
| IGM Biosciences, Inc. | -72.6 Million USD | -41.794% |
| INmune Bio, Inc. | -25.41 Million USD | -305.143% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 168.202% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -103.223% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -533.569% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -3468.584% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 370.817% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -149.972% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 422.882% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 127.239% |
| Verastem, Inc. | -37.27 Million USD | -176.171% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1034.696% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -98.51% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -580.218% |
| Histogen Inc. | -7.48 Million USD | -1275.063% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -376.475% |
| Surrozen, Inc. | -32.66 Million USD | -215.182% |
| Organovo Holdings, Inc. | -1.5 Million USD | -6731.52% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2349.18% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 642.985% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 4035.436% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2577.166% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1128.364% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -136.985% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -606.263% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 67.502% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -14157.956% |
| Apollomics, Inc. | -27.39 Million USD | -275.802% |
| Amarin Corporation plc | -191.04 Million USD | 46.11% |
| Mesoblast Limited | 55.96 Million USD | 283.963% |
| Turnstone Biologics Corp. | -14.58 Million USD | -605.917% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -307.05% |
| Synaptogenix, Inc. | -28.66 Million USD | -259.196% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -10899.038% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 311.26% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11842.038% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1316.871% |
| Exelixis, Inc. | -73.05 Million USD | -40.932% |
| Better Therapeutics, Inc. | -860 Thousand USD | -11871.047% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -328.73% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 57.347% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 14086.653% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1284.097% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 8309.809% |
| Gritstone bio, Inc. | 39.49 Million USD | 360.701% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -22.414% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3811.304% |
| Avid Bioservices, Inc. | 169.72 Million USD | 160.656% |
| Insmed Incorporated | 721.62 Million USD | 114.267% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1026.192% |
| MediWound Ltd. | -5.32 Million USD | -1834.442% |
| OmniAb, Inc. | 9.2 Million USD | 1218.668% |
| Alector, Inc. | -35.63 Million USD | -188.888% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 219.751% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1989.103% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 877.634% |
| Zai Lab Limited | -775 Million USD | 86.716% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 130.23% |
| Aura Biosciences, Inc. | -21.52 Million USD | -378.286% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -24.819% |
| Immunic, Inc. | -45.34 Million USD | -127.064% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 46.717% |
| Veracyte, Inc. | -203.82 Million USD | 49.49% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 116.129% |
| FibroGen, Inc. | 56.76 Million USD | 281.357% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1256.103% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -3541.599% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4872.642% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.243% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2981.443% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 37.968% |
| TG Therapeutics, Inc. | 17.86 Million USD | 676.369% |
| Galecto, Inc. | -21.21 Million USD | -385.252% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -332.84% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 106.56% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -320.689% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -794.681% |
| XBiotech Inc. | -200.02 Million USD | 48.53% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -22.414% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2373.653% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -191.952% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -33.325% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1909.014% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 39.588% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -11.45% |
| Vaxxinity, Inc. | 10.13 Million USD | 1116.098% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 113.983% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -856.123% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -56.09% |
| NexImmune, Inc. | -3.13 Million USD | -3185.346% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2881.777% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -581.278% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -279.893% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1046.952% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -82541.782% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -153.749% |
| Ainos, Inc. | 4.07 Million USD | 2624.591% |
| Pluri Inc. | 22.82 Million USD | 550.966% |
| Prothena Corporation plc | -608.34 Million USD | 83.077% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 13.309% |
| Celularity Inc. | 65.19 Million USD | 257.925% |
| Rallybio Corporation | -24.1 Million USD | -327.147% |
| Cue Biopharma, Inc. | -33.81 Million USD | -204.418% |
| MeiraGTx Holdings plc | -40.3 Million USD | -155.449% |
| Omeros Corporation | 331.17 Million USD | 131.086% |
| Humacyte, Inc. | -22.48 Million USD | -357.845% |
| Immunocore Holdings plc | -358.59 Million USD | 71.29% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -318.926% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -233.164% |
| Blueprint Medicines Corporation | 702.83 Million USD | 114.648% |
| CalciMedica, Inc. | -5.53 Million USD | -1761.682% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 45.303% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -907.94% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -157.14% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -209.599% |
| Pulmatrix, Inc. | -10.41 Million USD | -888.298% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1622.453% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -169.915% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 7.586% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -71.745% |
| Cytokinetics, Incorporated | 642.37 Million USD | 116.027% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1668.006% |
| Nutriband Inc. | -251.65 Thousand USD | -40809.253% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -201.741% |
| Vor Biopharma Inc. | 4.3 Million USD | 2494.209% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.294% |
| Evogene Ltd. | -19.63 Million USD | -424.351% |
| ProKidney Corp. | -56.23 Million USD | -83.07% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -111.52% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1014.528% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 107.548% |
| CorMedix Inc. | -43.05 Million USD | -139.129% |
| BioLineRx Ltd. | 7.33 Million USD | 1503.367% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -274.844% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 323.094% |
| Atai Life Sciences N.V. | -28.55 Million USD | -260.498% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 4715.542% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -351.223% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 680.496% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -37.133% |
| MediciNova, Inc. | -50.78 Million USD | -102.725% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -30.64% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -457561.703% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1495.499% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 48.478% |
| Biomea Fusion, Inc. | -166.57 Million USD | 38.194% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 42.477% |
| Mereo BioPharma Group plc | -51.46 Million USD | -100.025% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -8.548% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 64.954% |
| Absci Corporation | -72.59 Million USD | -41.81% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2354.731% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 56.086% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -9.277% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -7.581% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -163.484% |
| Allakos Inc. | -24.97 Million USD | -312.216% |
| Imunon, Inc. | -4.21 Million USD | -2343.157% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -598.352% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 23.965% |
| BioAtla, Inc. | -109.01 Million USD | 5.559% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 14086.653% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -10863.898% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 960.363% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -385.549% |
| XOMA Corporation | -29 Million USD | -255.003% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -521.685% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1041.87% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1282.078% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 17.399% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 50.543% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -25.889% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -10.983% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -11882.416% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2577.529% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 6443.683% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 107.455% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -8564.924% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2444.591% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 190.721% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 143163.005% |
| Orgenesis Inc. | 21.78 Million USD | 572.599% |
| Entera Bio Ltd. | -10.62 Million USD | -868.586% |
| GH Research PLC | -78.07 Million USD | -31.858% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -361.912% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -286.177% |
| Xencor, Inc. | 29.64 Million USD | 447.291% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -5126.438% |
| Replimune Group, Inc. | 1.41 Million USD | 7391.147% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -41936.601% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 18.562% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -8564.924% |
| Portage Biotech Inc. | -4.98 Million USD | -1966.874% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -457561.703% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -55.699% |
| OncoCyte Corporation | -6.56 Million USD | -1468.658% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 11571.976% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2159.857% |
| Purple Biotech Ltd. | -14.13 Million USD | -628.186% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -333.368% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1472.972% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -516.762% |
| HilleVax, Inc. | -165.48 Million USD | 37.788% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3956.383% |
| Tharimmune, Inc. | -10.93 Million USD | -841.451% |
| Genprex, Inc. | -6.73 Million USD | -1428.0% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 72.085% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -16.381% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -7248.394% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3003.789% |
| OKYO Pharma Limited | -826.84 Thousand USD | -12351.019% |
| Savara Inc. | 153 Thousand USD | 67388.235% |
| Curis, Inc. | -23.88 Million USD | -330.992% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1895.982% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -13166.676% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1558.36% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 8787.848% |
| BeiGene, Ltd. | -2.25 Billion USD | 95.431% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 934.388% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 83.073% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 44.527% |
| Erasca, Inc. | -37.21 Million USD | -176.631% |
| bluebird bio, Inc. | 108.57 Million USD | 194.824% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7893.754% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 127.182% |
| DBV Technologies S.A. | -126.98 Million USD | 18.927% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -7893.754% |
| Moderna, Inc. | -2.9 Billion USD | 96.459% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -894.503% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -847.286% |
| Molecular Templates, Inc. | 707 Thousand USD | 14661.669% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -228.173% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 129.702% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -25.455% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -12.233% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -219.01% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -199.485% |
| MacroGenics, Inc. | -66.98 Million USD | -53.693% |
| RenovoRx, Inc. | -1.17 Million USD | -8676.726% |
| Adicet Bio, Inc. | -138.78 Million USD | 25.821% |
| Prime Medicine, Inc. | -27.94 Million USD | -268.459% |
| Aditxt, Inc. | 18.12 Million USD | 668.135% |
| Adagene Inc. | -87.62 Million USD | -17.487% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2371.559% |
| Quantum-Si incorporated | -118.55 Million USD | 13.163% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 385.935% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1277.421% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -112.231% |
| SciSparc Ltd. | -2.06 Million USD | -4885.521% |
| Vericel Corporation | 1.27 Million USD | 8161.942% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -758.519% |
| Minerva Neurosciences, Inc. | 41 Million USD | 351.074% |
| Generation Bio Co. | 31.44 Million USD | 427.369% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 41.293% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -232.927% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 188.299% |
| Invivyd, Inc. | -198.47 Million USD | 48.129% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -14.048% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -4193.761% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -45.432% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1408.44% |
| 2seventy bio, Inc. | 181.71 Million USD | 156.655% |
| ADMA Biologics, Inc. | 90.06 Million USD | 214.306% |
| Clene Inc. | 3.34 Million USD | 3182.365% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1033.484% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -378.597% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1495.499% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 70.083% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -295.97% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 157.946% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2416.175% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2158.197% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1876.406% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 20.992% |
| Evaxion Biotech A/S | 5.28 Million USD | 2047.305% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 8.543% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 21.575% |
| Trevena, Inc. | 2.25 Million USD | 4659.389% |
| Surrozen, Inc. | -32.66 Million USD | -215.182% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -99.866% |
| Cingulate Inc. | 3.08 Million USD | 3439.656% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -3405.312% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1532.461% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1008.045% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -29.787% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 21.682% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 2.455% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2511.222% |
| Kronos Bio, Inc. | -36.05 Million USD | -185.547% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1194.176% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 7160.496% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -89.75% |
| Statera Biopharma, Inc. | 14.41 Million USD | 814.124% |
| ImmunityBio, Inc. | 618.22 Million USD | 116.653% |
| Korro Bio, Inc. | -132.94 Million USD | 22.56% |
| Kineta, Inc. | -4.54 Million USD | -2167.144% |
| BioVie Inc. | -17.73 Million USD | -480.583% |
| Codexis, Inc. | -43.27 Million USD | -137.921% |
| Celularity Inc. | 65.19 Million USD | 257.925% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3148.69% |
| Celcuity Inc. | 6.78 Million USD | 1617.666% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2959.516% |
| Cibus, Inc. | -8.07 Million USD | -1174.462% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2334.405% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2352.757% |
| IN8bio, Inc. | -16.38 Million USD | -528.171% |
| Kodiak Sciences Inc. | -103.87 Million USD | 0.89% |
| Annexon, Inc. | -193.75 Million USD | 46.865% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 286075.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -488.325% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2830.572% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 109.765% |
| Eyenovia, Inc. | 1.25 Million USD | 8279.14% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 482.646% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3074.561% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -209.655% |
| Arcellx, Inc. | -296.95 Million USD | 65.331% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -427.791% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -74.864% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -396.7% |
| Moolec Science SA | 117.61 Thousand USD | 87631.458% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -168.109% |
| Geron Corporation | 14.76 Million USD | 797.453% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -171.51% |
| Royalty Pharma plc | 5.65 Billion USD | 101.819% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 27.202% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1372.954% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1819.704% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 26.846% |
| Humacyte, Inc. | -22.48 Million USD | -357.845% |
| Structure Therapeutics Inc. | -124.33 Million USD | 17.201% |
| 89bio, Inc. | -289.05 Million USD | 64.383% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -307.856% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -5674.033% |
| Genelux Corporation | -6.89 Million USD | -1392.26% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -231.469% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 223.149% |
| Notable Labs, Ltd. | -9.77 Million USD | -953.099% |
| Liquidia Corporation | -80.17 Million USD | -28.406% |
| Mustang Bio, Inc. | -3.73 Million USD | -2655.648% |
| Immunovant, Inc. | -635.22 Million USD | 83.793% |
| Quantum-Si incorporated | -118.55 Million USD | 13.163% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -486.148% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2384.938% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1382.559% |
| Acasti Pharma Inc. | -23 Million USD | -347.516% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2957.44% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -533.569% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 25.257% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3203.564% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -363.076% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -454.424% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 39.182% |
| PepGen Inc. | -60.67 Million USD | -69.69% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -348.081% |
| United Therapeutics Corporation | -507.7 Million USD | 79.722% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -438.278% |
| Solid Biosciences Inc. | -47.75 Million USD | -115.604% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -11842.038% |
| Immuneering Corporation | -54.94 Million USD | -87.378% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2349.18% |
| Silo Pharma, Inc. | -3.52 Million USD | -2821.169% |
| Belite Bio, Inc | -87.27 Million USD | -17.967% |
| XOMA Corporation | -29 Million USD | -255.003% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -45.623% |
| Bionomics Limited | 227 Million USD | 145.351% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 11.464% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3964.39% |
| Cassava Sciences, Inc. | -121.13 Million USD | 15.012% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2371.559% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 351.4% |
| Forte Biosciences, Inc. | -11.96 Million USD | -760.722% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -3227.225% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 97223.585% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3074.561% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1256.103% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1288.228% |
| Altimmune, Inc. | -134.48 Million USD | 23.449% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 151.978% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3964.39% |
| Compugen Ltd. | -12.9 Million USD | -697.822% |
| Peak Bio, Inc. | 10.34 Million USD | 1095.642% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -36278.445% |
| Benitec Biopharma Inc. | -50.58 Million USD | -103.533% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1.329% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 624.057% |
| Zura Bio Limited | -99.8 Million USD | -3.151% |
| PolyPid Ltd. | 6.17 Million USD | 1768.574% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 238.898% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 624.057% |
| Instil Bio, Inc. | 75.35 Million USD | 236.616% |
| argenx SE | -2.02 Billion USD | 94.926% |
| Immunome, Inc. | -97.02 Million USD | -6.103% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -357.662% |
| Verona Pharma plc | -220.44 Million USD | 53.298% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -43.5% |
| Shattuck Labs, Inc. | -121.42 Million USD | 15.214% |
| CervoMed Inc. | -7.79 Million USD | -1221.096% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 44.501% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2254.242% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 21.853% |
| Moolec Science SA | 117.61 Thousand USD | 87631.458% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -4399.652% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 747.557% |
| AnaptysBio, Inc. | -18.15 Million USD | -467.192% |
| Design Therapeutics, Inc. | -18.15 Million USD | -467.223% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -46.277% |
| NeurAxis, Inc. | 145.7 Thousand USD | 70759.574% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1016.587% |
| Lumos Pharma, Inc. | -28.49 Million USD | -261.32% |
| Achilles Therapeutics plc | -126.92 Million USD | 18.888% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -43.5% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -15600.212% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -395.58% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 7160.496% |
| Nutriband Inc. | -251.65 Thousand USD | -40809.253% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -681.649% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1283.75% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 130.262% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 533.752% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 76.993% |
| Palisade Bio, Inc. | -12.06 Million USD | -753.444% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 26.627% |
| Beam Therapeutics Inc. | -262.72 Million USD | 60.814% |
| Neurogene Inc. | -131.95 Million USD | 21.98% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 571.906% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2009.652% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 72.706% |
| Sesen Bio, Inc. | -112.55 Million USD | 8.531% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -3.095% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -4285.012% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -163.801% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -23.617% |
| Athira Pharma, Inc. | -88.99 Million USD | -15.677% |
| Vaccinex, Inc. | -1.28 Million USD | -7893.09% |
| HCW Biologics Inc. | 2.85 Million USD | 3703.874% |
| XOMA Corporation | -29 Million USD | -255.003% |
| Nektar Therapeutics | 210.24 Million USD | 148.968% |
| Arvinas, Inc. | -313.8 Million USD | 67.192% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 6443.683% |
| Merus N.V. | -192.88 Million USD | 46.625% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 271.628% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1383.871% |
| Rezolute, Inc. | -68.16 Million USD | -51.025% |
| Clene Inc. | 3.34 Million USD | 3182.365% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -680.701% |
| BeyondSpring Inc. | -13.75 Million USD | -648.462% |
| Synlogic, Inc. | -6.68 Million USD | -1440.03% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 9178.571% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1117.635% |
| Peak Bio, Inc. | 10.34 Million USD | 1095.642% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -24.91% |
| Krystal Biotech, Inc. | -350.23 Million USD | 70.605% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 182.941% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 39.081% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3160.89% |
| MannKind Corporation | 143.89 Million USD | 171.544% |
| Ikena Oncology, Inc. | -109.15 Million USD | 5.685% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1259.807% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -211.03% |
| Gossamer Bio, Inc. | 180.35 Million USD | 157.082% |
| CohBar, Inc. | -5.93 Million USD | -1635.891% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -246.077% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2354.731% |
| Legend Biotech Corporation | -949.39 Million USD | 89.156% |
| Mural Oncology plc | -255.84 Million USD | 59.76% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 419.575% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2085.498% |
| Disc Medicine, Inc. | -358.28 Million USD | 71.265% |
| Champions Oncology, Inc. | 4.81 Million USD | 2239.464% |
| REGENXBIO Inc. | 54.76 Million USD | 287.977% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -38184.983% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 31.831% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1042.376% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -27.599% |
| Vaxart, Inc. | -8.24 Million USD | -1149.254% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -105.164% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 19.042% |
| Cellectis S.A. | -43.85 Million USD | -134.753% |
| Longeveron Inc. | -2.9 Million USD | -3440.268% |
| Repare Therapeutics Inc. | -107.85 Million USD | 4.55% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 110.631% |
| Inozyme Pharma, Inc. | 12 Million USD | 957.639% |
| Revolution Medicines, Inc. | -608.2 Million USD | 83.073% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -8270.0% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 61.168% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 31.399% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -557.96% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -13812.297% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.924% |
| Denali Therapeutics Inc. | -74.86 Million USD | -37.516% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -758.519% |
| Veru Inc. | 4.77 Million USD | 2253.801% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -815.445% |
| Cingulate Inc. | 3.08 Million USD | 3439.656% |
| Passage Bio, Inc. | 4.58 Million USD | 2345.387% |
| Context Therapeutics Inc. | -14.44 Million USD | -612.472% |
| Exicure, Inc. | 5.84 Million USD | 1860.147% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 55.312% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -160.174% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 756.115% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -75.024% |
| Nuvalent, Inc. | -335.38 Million USD | 69.304% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 6036.03% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -38.223% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1058.054% |
| OmniAb, Inc. | 9.2 Million USD | 1218.668% |
| Anew Medical, Inc. | 1.43 Million USD | 7286.982% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 728.449% |
| Lipocine Inc. | -4.75 Million USD | -2065.296% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 6.262% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 775.931% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -103.223% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 513.591% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1431.781% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -56.396% |
| Ocugen, Inc. | -32.52 Million USD | -216.568% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -20.305% |
| Q32 Bio Inc. | -37.94 Million USD | -171.295% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -16293.471% |
| Alumis Inc. Common Stock | -13.52 Million USD | -660.965% |
| Equillium, Inc. | -22.39 Million USD | -359.767% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -302.656% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -215.542% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -41426.733% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 176.805% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 3319.231% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 31445.356% |
| Dominari Holdings Inc. | 195 Thousand USD | 52895.385% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1854.676% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1054.547% |
| Bio-Techne Corporation | 267.74 Million USD | 138.451% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -535.147% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 12.823% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1125.17% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -713.778% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 58.0% |
| Nkarta, Inc. | 57.29 Million USD | 279.673% |
| BioCardia, Inc. | 212 Thousand USD | 48661.792% |
| Iterum Therapeutics plc | 13.43 Million USD | 866.118% |